QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present a lung cancer case study to show how QIAGEN Clinical Insight (QCI™) allows you to optimize and scale your pipeline for the clinical interpretation of genetic variants—from sequence data to report sign-off—without sacrificing accuracy or utility. QCI Interpret is a flexible clinical decision support suite that is compatible with any NGS platform, running any assay, targeting somatic, hereditary, hematological or childhood cancers.